BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2012
View Archived Issues
Johnson & Johnson presents highlights of third quarter 2012
Read More
Recent clinical data support approval of canagliflozin
Read More
Gene polymorphism linked to acute lung injury in Gram-negative sepsis
Read More
Tocilizumab shows positive effects in patients with neuromyelitis optica
Read More
Novel PI3K and mTOR inhibitors patented by Pathway Therapeutics
Read More
Abbott updates pipeline progress of third quarter 2012
Read More
New gamma-secretase modulators prepared at Pfizer
Read More
Chugai presents interim phase II results for CH-5424802
Read More
Prozymex presents new DPP-I inhibitors
Read More
CHMP recommends approval of Krystexxa
Read More
New agents for bacterial infections synthesized by Actelion Pharmaceuticals
Read More
Natco Pharma prepares new salts of anticancer agent
Read More
Actelion submits macitentan NDA
Read More
Amgen patents novel pim inhibitors
Read More
A novel marker can predict the outcome in osteosarcoma
Read More
Alnylam and Genzyme form RNAi therapeutics alliance in Asia
Read More
NXT-182 prevents neuronal apoptosis in vitro and increases neurogenesis in vivo
Read More
Health Canada approves new drug submission for Cinryze
Read More
Derma Sciences to begin phase III DSC-127 program
Read More
Astellas Pharma launches Myrbetriq in U.S.
Read More
Kaken submits application in Japan for topical antifungal agent
Read More
Eisai obtains FDA approval for Fycompa
Read More
Ono and Domain Therapeutics enter GPCR collaboration
Read More
Health Canada approves Seebri Breezhaler for COPD
Read More
Ligand to receive milestone payment from Merck & Co.
Read More
Phase I trial of Kevetrin now active
Read More